Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Needs an Aspirin After Supreme Court Rejects Appeal
Wall St Cheat Sheet
Tuesday, December 10, 2013 - 10:43am
tags:
Pfizer, Supreme Court, Neurontin
Bristol drug for fat disorder may work, but risky - FDA staff
Reuters
Tuesday, December 10, 2013 - 9:46am
tags:
Bristol-Myers Squibb, FDA, metreleptin
J&J taps UK research hubs
The Telegraph, UK
Tuesday, December 10, 2013 - 9:44am
tags:
JNJ, R&D, UK
Boehringer to Pay $931,000 Fine Over Lost Pradaxa Files
Bloomberg
Tuesday, December 10, 2013 - 9:41am
tags:
Boehringer Ingelheim, Pradaxa
Novartis Said to Weigh Animal-Health Asset Swap
Bloomberg
Tuesday, December 10, 2013 - 9:38am
tags:
Novartis, animal health, Merck
EU regulators fine J&J, Novartis 16 mln euros for generic drug deal
Yahoo/Reuters
Tuesday, December 10, 2013 - 9:25am
tags:
Europe, Novartis, generics, JNJ, Fentanyl
Merck moves Alzheimer's drug into big trial after safety review
Yahoo/Reuters
Tuesday, December 10, 2013 - 9:22am
tags:
Merck, Alzheimer's disease, MK-8931
FDA staff cautious on AstraZeneca, Bristol diabetes drug
Yahoo/Reuters
Tuesday, December 10, 2013 - 9:21am
tags:
FDA, AstraZeneca, Bristol-Myers Squibb, Dapagliflozin, diabetes
Takeda Drug for Bowel Diseases Wins U.S. Panel's Backing
Bloomberg
Tuesday, December 10, 2013 - 9:18am
tags:
Takeda, FDA, advisory panels, vedolizumab
If Arena Has What It Takes, Why Is It Down?
Seeking Alpha
Tuesday, December 10, 2013 - 9:16am
tags:
Arena Pharmaceuticals, obesity, Belviq
Glaxo, Theravance Launch Relvar Ellipta in Japan
Motley Fool
Tuesday, December 10, 2013 - 9:15am
tags:
GSK, Relvar Ellipta, Theravance, Japan
Biggest Winners in Biotech This Year
Motley Fool
Tuesday, December 10, 2013 - 9:14am
tags:
Acadia, Puma Biotechnology, Alnylam, Celldex Therapeutics
Orexigen Therapeutics: Light at the End of the Tunnel?
Motley Fool
Tuesday, December 10, 2013 - 9:07am
tags:
obesity. Orexigen Therapeutics, Contrave
Merck agrees to settle litigation over Fosamax jaw injuries
Yahoo/Reuters
Monday, December 9, 2013 - 3:24pm
tags:
Merck, Fosamax
An In-Depth Look At 3 Companies Fighting GBM Brain Cancer
Seeking Alpha
Monday, December 9, 2013 - 3:11pm
tags:
glioblastoma multiforme, Agenus, ImmunoCellular Therapeutics, Northwest Biotherapeutics
Power struggle at Novartis? Not at all, new chairman says
Fierce Pharma
Monday, December 9, 2013 - 11:30am
tags:
Novartis, Joe Jimenez, Joerg Reinhardt
Celgene advances after analysts say Revlimid data positive
The Fly on the Wall
Monday, December 9, 2013 - 11:29am
tags:
Revlimid, Celgene, Multiple Myeloma
The silver lining on the medtech tax?
Mass Device
Monday, December 9, 2013 - 11:21am
tags:
devices, medical device tax
NVC-422 Gives NovaBay Huge Growth Potential
Seeking Alpha
Monday, December 9, 2013 - 11:20am
tags:
NVC-422, NovaBay Pharmaceuticals, adenoviral conjunctivitis
Pfizer Rejected by Top Court on Neurontin Marketing Suits
Bloomberg
Monday, December 9, 2013 - 11:18am
tags:
Pfizer, Neurontin, insurance fraud

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.